A Randomised Trial of the Cost Effectiveness of Screening and Intensive Multi-factorial Intervention for Type 2 Diabetes View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2004-2015

ABSTRACT

Diabetes is a common chronic condition associated with the risk of heart disease, and eye and kidney damage. Many people are diagnosed with diabetes when they develop symptoms or complications, suggesting that the true onset of disease occurs years earlier. Early detection of diabetes may result in health benefits, but this is not proven. People of South Asian origin are at more risk of having diabetes and of getting the heart disease complications associated with it. The study aims to test whether screening for diabetes is feasible in a South Asian population and to measure the benefits of early detection and intensive treatment. Hypothesis: A program of screening and an intensive multi-factorial intervention for type 2 diabetes is both feasible and cost effective within primary care. Detailed Description Although diabetes is commonly undiagnosed and many patients have evidence of complications at diagnosis, there is no definitive evidence that early detection improves health outcomes. One of the critical but uncertain factors is the extent to which screening and subsequent treatment reduces cardiovascular risk. Multi-factorial cardiovascular risk reduction in people with prevalent diabetes and microalbuminuria results in a halving of heart disease risk. However, it is not certain whether this result can be generalised to patients without microalbuminuria or those whose disease is screen-detected. The ADDITION study is a collaborative randomised controlled trial of a target-driven intensive multi-factorial approach to cardiovascular risk reduction in patients with screen-detected type 2 diabetes mellitus, aimed at assessing the feasibility of screening in a primary care setting and quantifying the cardiovascular benefits and economic and psychological costs of screening. The study as a whole will have the power to determine whether screening and the intensive multi-factorial intervention results in improved cardiovascular outcomes. The ADDITON-Leicester study will contribute to this collaboration, but which by itself will demonstrate the feasibility of screening and measure the effect of the ADDITION study intervention on modelled cardiovascular risk at 1 year after detection by screening in a population at high risk by virtue of having a high proportion of people from South Asia (Leicester). The study is also assessing the impact of intensive intervention of modelled cardiovascular risk at 1 year. People of South Asian origin are at increased risk of having diabetes and of developing heart disease. The issues of screening are thus particularly relevant to this population. However, all of the populations currently recruited to ADDITION are predominantly Caucasian. The ADDITION-Leicester study will assess the feasibility of systematic screening in a South Asian population, will quantify the effect of intensive treatment in people with screen detected diabetes on modelled cardiovascular risk at 1 year and will assess the economic and psychological costs of screening and intensive treatment. This study population will then contribute to the ADDITION-Europe study, which as a whole is powered to assess the impact of screening and intensive treatment on 5 year cardiovascular outcomes. More... »

URL

https://clinicaltrials.gov/show/NCT00318032

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3177", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Diabetes is a common chronic condition associated with the risk of heart disease, and eye and kidney damage. Many people are diagnosed with diabetes when they develop symptoms or complications, suggesting that the true onset of disease occurs years earlier. Early detection of diabetes may result in health benefits, but this is not proven. People of South Asian origin are at more risk of having diabetes and of getting the heart disease complications associated with it. The study aims to test whether screening for diabetes is feasible in a South Asian population and to measure the benefits of early detection and intensive treatment. Hypothesis: A program of screening and an intensive multi-factorial intervention for type 2 diabetes is both feasible and cost effective within primary care.\n\nDetailed Description\nAlthough diabetes is commonly undiagnosed and many patients have evidence of complications at diagnosis, there is no definitive evidence that early detection improves health outcomes. One of the critical but uncertain factors is the extent to which screening and subsequent treatment reduces cardiovascular risk. Multi-factorial cardiovascular risk reduction in people with prevalent diabetes and microalbuminuria results in a halving of heart disease risk. However, it is not certain whether this result can be generalised to patients without microalbuminuria or those whose disease is screen-detected. The ADDITION study is a collaborative randomised controlled trial of a target-driven intensive multi-factorial approach to cardiovascular risk reduction in patients with screen-detected type 2 diabetes mellitus, aimed at assessing the feasibility of screening in a primary care setting and quantifying the cardiovascular benefits and economic and psychological costs of screening. The study as a whole will have the power to determine whether screening and the intensive multi-factorial intervention results in improved cardiovascular outcomes. The ADDITON-Leicester study will contribute to this collaboration, but which by itself will demonstrate the feasibility of screening and measure the effect of the ADDITION study intervention on modelled cardiovascular risk at 1 year after detection by screening in a population at high risk by virtue of having a high proportion of people from South Asia (Leicester). The study is also assessing the impact of intensive intervention of modelled cardiovascular risk at 1 year. People of South Asian origin are at increased risk of having diabetes and of developing heart disease. The issues of screening are thus particularly relevant to this population. However, all of the populations currently recruited to ADDITION are predominantly Caucasian. The ADDITION-Leicester study will assess the feasibility of systematic screening in a South Asian population, will quantify the effect of intensive treatment in people with screen detected diabetes on modelled cardiovascular risk at 1 year and will assess the economic and psychological costs of screening and intensive treatment. This study population will then contribute to the ADDITION-Europe study, which as a whole is powered to assess the impact of screening and intensive treatment on 5 year cardiovascular outcomes.", 
    "endDate": "2015-11-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00318032", 
    "keywords": [
      "cost-effectiveness", 
      "Mass Screening", 
      "intervention", 
      "diabetes", 
      "common chronic condition", 
      "risk", 
      "heart disease", 
      "eye", 
      "kidney damage", 
      "symptom", 
      "complication", 
      "onset", 
      "disease", 
      "early detection", 
      "Insurance Benefit", 
      "South", 
      "origin", 
      "disease complication", 
      "Asian population", 
      "benefit", 
      "intensive treatment", 
      "type 2 diabetes", 
      "Primary Health Care", 
      "patient", 
      "evidence", 
      "diagnosis", 
      "definitive evidence", 
      "health outcome", 
      "subsequent treatment", 
      "cardiovascular risk", 
      "cardiovascular risk reduction", 
      "microalbuminuria", 
      "heart disease risk", 
      "addition study", 
      "target", 
      "diabetes mellitus", 
      "feasibility", 
      "primary care setting", 
      "cardiovascular benefit", 
      "Economics", 
      "power", 
      "intervention result", 
      "cardiovascular outcome", 
      "Leicester", 
      "Cooperative Behavior", 
      "Weight and Measure", 
      "study intervention", 
      "population", 
      "high risk", 
      "virtue", 
      "high proportion", 
      "South Asia", 
      "intensive intervention", 
      "increased risk", 
      "systematic screening", 
      "study population", 
      "Europe"
    ], 
    "name": "A Randomised Trial of the Cost Effectiveness of Screening and Intensive Multi-factorial Intervention for Type 2 Diabetes", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00318032"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00002.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.419248.2", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.269014.8", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.57981.32", 
        "type": "Organization"
      }
    ], 
    "startDate": "2004-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1177/1479164112451473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002820812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-011-2189-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011380450", 
          "https://doi.org/10.1007/s00125-011-2189-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-011-2189-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011380450", 
          "https://doi.org/10.1007/s00125-011-2189-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1745-6215-11-16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024227117", 
          "https://doi.org/10.1186/1745-6215-11-16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0026464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027306550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0050931", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028621129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2014-006076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031085817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc11-2079", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033056052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mayocp.2017.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085746700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mayocp.2017.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085746700"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00318032"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00318032'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00318032'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00318032'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00318032'


 

This table displays all metadata directly associated to this object as RDF triples.

109 TRIPLES      16 PREDICATES      83 URIs      66 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00318032 schema:about anzsrc-for:3053
2 anzsrc-for:3177
3 schema:description Diabetes is a common chronic condition associated with the risk of heart disease, and eye and kidney damage. Many people are diagnosed with diabetes when they develop symptoms or complications, suggesting that the true onset of disease occurs years earlier. Early detection of diabetes may result in health benefits, but this is not proven. People of South Asian origin are at more risk of having diabetes and of getting the heart disease complications associated with it. The study aims to test whether screening for diabetes is feasible in a South Asian population and to measure the benefits of early detection and intensive treatment. Hypothesis: A program of screening and an intensive multi-factorial intervention for type 2 diabetes is both feasible and cost effective within primary care. Detailed Description Although diabetes is commonly undiagnosed and many patients have evidence of complications at diagnosis, there is no definitive evidence that early detection improves health outcomes. One of the critical but uncertain factors is the extent to which screening and subsequent treatment reduces cardiovascular risk. Multi-factorial cardiovascular risk reduction in people with prevalent diabetes and microalbuminuria results in a halving of heart disease risk. However, it is not certain whether this result can be generalised to patients without microalbuminuria or those whose disease is screen-detected. The ADDITION study is a collaborative randomised controlled trial of a target-driven intensive multi-factorial approach to cardiovascular risk reduction in patients with screen-detected type 2 diabetes mellitus, aimed at assessing the feasibility of screening in a primary care setting and quantifying the cardiovascular benefits and economic and psychological costs of screening. The study as a whole will have the power to determine whether screening and the intensive multi-factorial intervention results in improved cardiovascular outcomes. The ADDITON-Leicester study will contribute to this collaboration, but which by itself will demonstrate the feasibility of screening and measure the effect of the ADDITION study intervention on modelled cardiovascular risk at 1 year after detection by screening in a population at high risk by virtue of having a high proportion of people from South Asia (Leicester). The study is also assessing the impact of intensive intervention of modelled cardiovascular risk at 1 year. People of South Asian origin are at increased risk of having diabetes and of developing heart disease. The issues of screening are thus particularly relevant to this population. However, all of the populations currently recruited to ADDITION are predominantly Caucasian. The ADDITION-Leicester study will assess the feasibility of systematic screening in a South Asian population, will quantify the effect of intensive treatment in people with screen detected diabetes on modelled cardiovascular risk at 1 year and will assess the economic and psychological costs of screening and intensive treatment. This study population will then contribute to the ADDITION-Europe study, which as a whole is powered to assess the impact of screening and intensive treatment on 5 year cardiovascular outcomes.
4 schema:endDate 2015-11-01T00:00:00Z
5 schema:keywords Asian population
6 Cooperative Behavior
7 Economics
8 Europe
9 Insurance Benefit
10 Leicester
11 Mass Screening
12 Primary Health Care
13 South
14 South Asia
15 Weight and Measure
16 addition study
17 benefit
18 cardiovascular benefit
19 cardiovascular outcome
20 cardiovascular risk
21 cardiovascular risk reduction
22 common chronic condition
23 complication
24 cost-effectiveness
25 definitive evidence
26 diabetes
27 diabetes mellitus
28 diagnosis
29 disease
30 disease complication
31 early detection
32 evidence
33 eye
34 feasibility
35 health outcome
36 heart disease
37 heart disease risk
38 high proportion
39 high risk
40 increased risk
41 intensive intervention
42 intensive treatment
43 intervention
44 intervention result
45 kidney damage
46 microalbuminuria
47 onset
48 origin
49 patient
50 population
51 power
52 primary care setting
53 risk
54 study intervention
55 study population
56 subsequent treatment
57 symptom
58 systematic screening
59 target
60 type 2 diabetes
61 virtue
62 schema:name A Randomised Trial of the Cost Effectiveness of Screening and Intensive Multi-factorial Intervention for Type 2 Diabetes
63 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00318032
64 schema:sdDatePublished 2019-03-07T15:22
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher N6cd4e19fd19d443c8f3a317b4f9c8026
67 schema:sponsor https://www.grid.ac/institutes/grid.269014.8
68 https://www.grid.ac/institutes/grid.419248.2
69 https://www.grid.ac/institutes/grid.57981.32
70 schema:startDate 2004-08-01T00:00:00Z
71 schema:subjectOf sg:pub.10.1007/s00125-011-2189-2
72 sg:pub.10.1186/1745-6215-11-16
73 https://doi.org/10.1016/j.mayocp.2017.02.009
74 https://doi.org/10.1136/bmjopen-2014-006076
75 https://doi.org/10.1177/1479164112451473
76 https://doi.org/10.1371/journal.pone.0026464
77 https://doi.org/10.1371/journal.pone.0050931
78 https://doi.org/10.2337/dc11-2079
79 schema:url https://clinicaltrials.gov/show/NCT00318032
80 sgo:license sg:explorer/license/
81 sgo:sdDataset clinical_trials
82 rdf:type schema:MedicalStudy
83 N6cd4e19fd19d443c8f3a317b4f9c8026 schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
86 rdf:type schema:DefinedTerm
87 anzsrc-for:3177 schema:inDefinedTermSet anzsrc-for:
88 rdf:type schema:DefinedTerm
89 sg:pub.10.1007/s00125-011-2189-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011380450
90 https://doi.org/10.1007/s00125-011-2189-2
91 rdf:type schema:CreativeWork
92 sg:pub.10.1186/1745-6215-11-16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024227117
93 https://doi.org/10.1186/1745-6215-11-16
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1016/j.mayocp.2017.02.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085746700
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1136/bmjopen-2014-006076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031085817
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1177/1479164112451473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002820812
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1371/journal.pone.0026464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027306550
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1371/journal.pone.0050931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028621129
104 rdf:type schema:CreativeWork
105 https://doi.org/10.2337/dc11-2079 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033056052
106 rdf:type schema:CreativeWork
107 https://www.grid.ac/institutes/grid.269014.8 schema:Organization
108 https://www.grid.ac/institutes/grid.419248.2 schema:Organization
109 https://www.grid.ac/institutes/grid.57981.32 schema:Organization
 




Preview window. Press ESC to close (or click here)


...